Latest news


Genomics plays a vital role in driving Québec's economic future. That is why Génome Québec aims at advancing knowledge in genomics by funding major research projects. In this section, you will discover all the latest achievements in the field of genomics.

Stratégie québécoise de recherche et d'investissement en innovation 2022-2027 - A more than promising future for the development of genomics

May 19, 2022

Stratégie québécoise de recherche et d'investissement en innovation 2022-2027 - A more than promising future for the development of genomics


Montréal, May 19, 2022 - Génome Québec welcomes with enthusiasm and confidence the new Stratégie québécoise de recherche et d'investissement en innovation (SQRI2) 2022-2027, launched this morning by the ministre de l'Économie et de l'Innovation, Mr. Pierre Fitzgibbon. With a planned investment of $7.5 billion over five years, the SQRI2 proposes five areas of intervention and 12 key actions, which aim to rely on innovation to increase the prosperity of all Quebecers.

  

"Over the past 20 years, more than $1 billion has been invested to support innovation in genomics, including $400 million from the Québec government, which took risks in the early 2000s and has continued to support the development of this innovative technology ever since. Thanks to the assets built up over time, genomics offers immense potential to help Québec create more economic and social wealth. The new SQRI2 2022-2027 and its $7.5 billion envelope will certainly allow us to pursue this growth and make this disruptive technology a concrete part of Québec's socio-economic development," said Daniel Coderre, President and CEO of Génome Québec.

 

To read the full Press release (French only)

 



More details...

Launch of the Genome Canada Climate Action Genomics Initiative - Climate -Smart Agriculture and Food Systems

May 16, 2022

New $30M genomics initiative to reduce carbon footprint and support economic growth of Canadian agriculture and food systems

 

Genome Canada’s challenge-driven genomics initiative will support climate change mitigation and adaptation through strategic investment in climate-smart agriculture and food systems.


More details...

Launch of Genovalia, the first non-human genomic data exploitation centre in Québec

Apr. 12, 2022

Génome Québec and Université Laval are proud to announce the launch of Genovalia, the very first centre dedicated to the production, processing and exploitation of non-human genomic data in Québec. This initiative will create value by building on the synergy between artificial intelligence and genomic data in sectors such as agrifood, forestry and environmental sciences.


More details...

Génome Québec welcomes $1.4 billion investment to support research and innovation

Mar. 22, 2022

The 2022-2023 budget provides $1.4 billion over five years to support and research and innovation Génome Québec is delighted with this announcement.  

 

"Thanks to the Québec government's constant support over the years, Québec now has a critical mass of expertise and enviable infrastructures that allow us to position ourselves as a key player in the bioeconomy, and thus remain a leader in Canada and internationally. These new investments will increase our competitiveness," said Daniel Coderre, CEO of Génome Québec.


More details...

Laurent Tessier, saved by genomic profiling

Jan. 11, 2022

Laurent Tessier, 17, survived a virulent cancer thanks to a genetic research program launched to provide young people with personalized treatments.

 

At CHU Sainte-Justine in 2012, this precision medicine research program in pediatric oncology (called TRICEPS) was a first in the field.

 

Daniel Sinnett, a geneticist, and co-director of the TRICEPS program oversaw this treatment within the program and stipulates that many other young people in Quebec have been saved by discovering treatment options tailored to each patient.

 

This article explains how precision medicine, through genomic profiling, has saved the lives of many young patients, including Laurent Tessier.


More details...